Tarsus prices $100M public offering of 5.71M shares at $17.50/share

Tarsus Pharmaceuticals, Inc.

Net proceeds expected to be ~$93.6M after underwriting discounts and offering expenses.
Underwriters granted 30-day option to purchase up to an additional 857,142 shares.
Joint book-running managers: Goldman Sachs, BofA Securities, Guggenheim Securities, Oppenheimer.
Offering expected to close on August 4, 2023, subject to customary closing conditions.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Tarsus Pharmaceuticals, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC, acting as representatives of the underwriters valued at approximately $93.6 million (effective 2023-08-01).

Action: entry
Agreement: underwriting
Counterparty: Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC, acting as representatives of the underwriters
Value: approximately $93.6 million
Effective: 2023-08-01

Exact text from the filing

On August 1, 2023, Tarsus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), entered into an Underwriting Agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC, acting as representatives of the underwriters named in the Underwriting Agreement (the “Underwriters”), relating to the sale of 5,714,285 shares of the Company’s common stock, par value $0.0001 per share (the “Offering”).

View on SEC.gov

Browse all material agreements →

Tarsus Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-201717

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.